Categories
Archives
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
Jun
27
UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder
Jun
20
UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference
Jun
17
Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by myasthenia gravis in the U.S.
Jun
13
Tu Salud Tu Familia Generates Awareness for Rare Diseases such as Myasthenia Gravis
Jun
12
UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity
Jun
11
BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of Inflammation in Psoriatic Arthritis and Axial Spondyloarthritis
Jun
04
Resources for Resilience: Dravet Syndrome Awareness Month for Families Living with DEEs
